The use of gonadotropin-releasing hormone (GnRH) agonist to induce oocyte maturation after cotreatment with GnRH antagonist in high-risk patients undergoing in vitro fertilization prevents the risk of ovarian hyperstimulation syndrome: a prospective randomized controlled study
Fertility and sterility, 2008, Vol.89 (1), p.84-91 [Peer Reviewed Journal]American Society for Reproductive Medicine ;2008 American Society for Reproductive Medicine ;2008 INIST-CNRS ;ISSN: 0015-0282 ;EISSN: 1556-5653 ;DOI: 10.1016/j.fertnstert.2007.02.002 ;PMID: 17462639 ;CODEN: FESTAS
Full text available